Alnylam Pharmaceuticals
ALNY
#624
Rank
NZ$69.07 B
Marketcap
NZ$517.40
Share price
3.78%
Change (1 day)
2.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company